Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
CARPROFEN
Norbrook Laboratories Limited
QM01AE91
CARPROFEN
100 Milligram
Tablets
POM
Canine
Carprofen
N.S.A.I.D
Authorised
2010-01-08
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Carprieve 100 mg Tablets for Dogs. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains: ACTIVE INGREDIENTS: Carprofen 100 mg EXCIPIENTS: Tartrazine (E102) 1.2 mg For the full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Tablet. A yellow circular tablet of 8 mm diameter, embossed “100” on one side and a single breakline on the other side. The tablets can be divided into halves. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES In the dog: Reduction of inflammation and pain caused by musculoskeletal disorders and degenerative joint disease. As a follow up to parenteral analgesia in the management of post operative pain. 4.3 CONTRAINDICATIONS Do not use in cats. Do not use in pregnant or lactating bitches. Do not use in puppies less than 4 months of age. Do not use in animals with known hypersensitivity to the active substance or to any of the excipients.” Do not use in dogs suffering from cardiac, hepatic or renal disease, where there is a possibility of gastrointestinal ulceration or bleeding, or where there is evidence of a blood dyscrasia. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Refer to Sections 4.3 and 4.5. HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 04/07/2014_ _CRN 7015268_ _page number: 1_ 4.5 SPECIAL PRECAUTIONS FOR USE i. Special precautions for use in animals Use in aged dogs may involve additional risk. If such a use cannot be avoided, such dogs may require a reduced dosage and careful clinical management. NSAIDs can cause inhibition of phagocytosis and hence in the treatment of inflammatory con Read the complete document